LW195 QUP IMP Support - Castlevax

The Liverpool School of Tropical Medicine is seeking a qualified and authorized supplier under solicitation LW195 to provide Qualified Person (QP) services and associated support for the COVAXCHIM002 Phase 2b clinical trial. The scope of work includes the delivery of Good Manufacturing Practice (GMP) services, regulatory support, importation, labelling, and clinical trial supply services. These operations will be conducted across the United Kingdom, Belgium, and Singapore. The contract is estimated to run from January 11, 2027, to January 10, 2029, with the possibility of two one-year extensions extending the performance period to January 10, 2031. The estimated total value of the contract is 100,000 GBP excluding VAT, or 120,000 GBP including VAT. Award decisions will be based on quality and price criteria as detailed in the tender documents. This opportunity is noted as particularly suitable for small and medium-sized enterprises (SME) and voluntary, community, and social enterprises (VCSE). Interested parties must submit their responses electronically via the designated eSourcing portal by the deadline of November 30, 2026, at 1:00 pm.